The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
New England Journal of MedicinePublished 30 September 1993Open access
David M. Nathan
Citations24,537
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Abstract
Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Keywords
Medicine
OphthalmologyGrading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House Classification
1,992 Citations1991
Archives of OphthalmologyThe Wisconsin Epidemiologic Study of Diabetic Retinopathy
1,872 Citations1984Ronald Klein
In a population-based study in southern Wisconsin, 996 insulin-taking, younger-onset diabetic persons were examined using standard protocols to determine the prevalence and severity of diabetic retinopathy and associated risk variables.
Archives of OphthalmologyThe Wisconsin Epidemiologic Study of Diabetic Retinopathy
1,471 Citations1984Ronald Klein
The severity of retinopathy was found to be related to longer duration of diabetes, younger age at diagnosis, higher glycosylated hemoglobin levels, higher systolic BP, use of insulin, presence of proteinuria, and small body mass.
OphthalmologyEarly Photocoagulation for Diabetic Retinopathy
1,255 Citations1991E Gregersen, Hans‐Walther Larsen
New England Journal of MedicineThe Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus
1,217 Citations1993Per Reichard, Bengt-Yngve Nilsson +1 more
Long-term intensified insulin treatment, as compared with standard treatment, retards the development of microvascular complications in patients with insulin-dependent diabetes mellitus.
OphthalmologyFundus Photographic Risk Factors for Progression of Diabetic Retinopathy
801 Citations1991
Severity of intraretinal microvascular abnormalities, hemorrhages and/or microaneurysms, and venous beading were found to be the most important factors in predicting progression to proliferative retinopathy.
Diabetes CareReliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT)
516 Citations1988The DCCT Research Group
The DQOL and its four scales had high degrees of internal consistency, excellent test-retest reliability and convergent validity, and may be useful in evaluating the quality of life in other groups of patients with IDDM.
Diabetes CareDiabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group
476 Citations1987
The feasibility phase of the DCCT demonstrated that a complex multicenter, randomized study of the relationship between diabetes control and complications can be performed, and the full-scale, long-term trial therefore has been initiated.
DiabetologiaPrognosis of diabetics with diabetes onset before the age of thirtyone
474 Citations1978T. Deckert, Jacob E. Poulsen +1 more
Clinical manifestations of late diabetic complications were considerably less common in patients who were still alive after more than forty years of diabetes than in Patients who died before their fortieth year of diabetes.
New England Journal of MedicineBlood Glucose Control and the Evolution of Diabetic Retinopathy and Albuminuria
466 Citations1984The Kroc Collaborative Study Group*
The LancetEFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES
452 Citations1986Bo Feldt‐Rasmussen, E. R. Mathiesen +1 more
36 patients with insulin-dependent diabetes mellitus who had 'Albustix'-negative urine but raised urinary albumin excretion were randomly assigned to either remaining on conventional insulin treatment or continuous subcutaneous insulin infusion and followed up for 2 years.
The LancetEFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICS
375 Citations1983Torsten Lauritzen, Hans‐Walther Larsen +3 more
Retinal function improved significantly with CSII treatment and deteriorated significantly with UCT, and changes in retinal function were most pronounced in patients with the best and the poorest regulated glycaemic control.
BMJRapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
366 Citations1985Knut Dahl‐Jørgensen, O Brinchmann-Hansen +3 more
A large and rapid fall in blood glucose concentration may promote transient deterioration of diabetic retinopathy, and patients who developed cotton wool spots are characterised by a larger decrement in glycosylated haemoglobin and blood glucose values.
Diabetes CareWeight Gain Associated With Intensive Therapy in the Diabetes Control and Complications Trial
343 Citations1988The DCCT Research Group
The results from the 1st yr of experience in the DCCT indicate that weight gain accompanies efforts to lower blood glucose levels with intensive insulin therapy, and improved utilization of calories through a decrease in glycosuria and perhaps other mechanisms led to the weight gain in the intensively treated subjects.
Controlled Clinical TrialsProperties of the urn randomization in clinical trials
305 Citations1988Lee‐Jen Wei, John M. Lachin
The large-sample permutational null distributions of linear rank statistics for testing the equality of treatment groups based on the urn design are described and a combined covariate-adjusted test of treatment effect is described.
DiabetesThe Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group
229 Citations1986
The DCCT and the considerations that led to the choice of specific design features for the feasibility phase are described, including the use of an intensive insulin regimen designed to maintain near-normal glycemic levels in the absence of severe hypoglycemia.
Diabetes CareDiabetes Control and Complications Trial (DCCT): Update
131 Citations1990DCCT Research Group
The rationale and design of the DCCT, changes in the protocol since its inception, study progress to date, including baseline characteristics of the entire study population, and the results of analyses of baseline data are reviewed.
Clinical ChemistryFeasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group.
124 Citations1987
Hb A1c evidently can be precisely and reliably measured in the context of a long-term, multicenter trial such as the DCCT, and results indicated no significant assay drift over time.
JAMAGlycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy
111 Citations1988Ronald Klein
Archives of OphthalmologyColor Photography vs Fluorescein Angiography in the Detection of Diabetic Retinopathy in the Diabetes Control and Complications Trial
107 Citations1987The Diabetes Control and Complications Trial Research Group
Archives of OphthalmologyThe Response of Diabetic Retinopathy to 41 Months of Multiple Insulin Injections, Insulin Pumps, and Conventional Insulin Therapy
99 Citations1988O Brinchmann-Hansen, Knut Dahl‐Jørgensen +2 more
Transient progression of retinopathy may be related to fluctuations in blood glucose levels, although a favorable effect of long-term improved metabolic control was not documented.
British Journal of OphthalmologyContinuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.
69 Citations1982P M Lawson, M C Champion +5 more
JAMAGlucose control and the renal and retinal complications of insulin-dependent diabetes
46 Citations1989H. Peter Chase
Controlled Clinical TrialsImplementation of a multicomponent process to obtain informed consent in the diabetes control and complications trial
43 Citations1989
The multicomponent informed consent process developed for the DCCT may serve as a model for other complex and demanding clinical trials where prospective subjects must be highly educated about the trial in order to participate effectively.
The American Journal of MedicineDiabetic autonomic neuropathy—part I
24 Citations1988M. Schumer, Gary V. Burton +3 more
To determine the feasibility of utilizing a central, computerized unit to analyze autonomic nervous system function tests for a 10-year, multicenter, clinical trial, the Autonomic Nervous System Reading Center was established.
Controlled Clinical TrialsOperational and policy considerations of data monitoring in clinical trials:
13 Citations1993Carolyn Siebert, Charles M. Clark
A distinctive aspect of the DCCT's DSQ is the creation of a free-standing operations manual for the DSQ's use during the trial and the involvement of the study investigators in developing certain sections of this document.